Allergy Diagnostics and Therapeutics Market
Allergy Diagnostics and Therapeutics Market By Allergens, By Product, By Test, By Drug Class , By End-User - Global Industry Share, Growth, Competitive Analysis And Forecast, 2017-2022
The Global Allergy Diagnostics and Therapeutics market is anticipated to grow with a CAGR 12.3% during the forecasted period 2017-2022. Increasing prevalence of the allergic diseases across the globe is one of the key factors that are augmenting the growth of the market. Additionally, increasing environmental pollution, rising health care expenditure, increasing demand of IVD test for treatment of allergic diseases and development of advanced diagnosis product are boosting the allergy diagnostics and therapeutics market across the globe.
Updated version (2019-2025) of the report
is available @ https://www.omrglobal.com/industry-reports/allergy-diagnostics-and-therapeutics-market-size
Allergic rhinitis affects around 15-30% of the population across the
globe. Allergic diseases are estimated to be the 6th leading cause of
chronic diseases in the US. An estimated 50 million people in America
suffer from the allergies every year. Increasing environmental pollution
is also one of the major factors driving the growth of the market.
According to WHO, approximately 90% of the cities in emerging economies
and more than 55% of cities in developed countries fail to comply with
WHO air quality guidelines. Increasing healthcare expenditure across the
globe is also one of the major factors driving the growth of the global
allergy diagnostics and therapeutics market.
However, there are certain factors that are affecting the growth of the
market which includes stringent government regulations on the use of
medical devices, lack of awareness, and high cost of treatment are the
major factors that are hindering the growth of the market. Except these
petty challenges global allergy diagnostics and therapeutic market is
yet to explore its full potential across the globe. Increasing demand
from the emerging economies such as India and China are developing
numerous expansion opportunities for the growth of the market.
Geographical insights
The global allergy diagnosis and therapeutics market is analyzed on the basis of the geographically region that are contributing significantly towards the growth of the market. Market on the basis of the geography is bifurcated into North America, Europe, Asia Pacific and Rest of the World. North America is estimated to be the leading region in the global allergy diagnosis and therapeutics market owing to increasing prevalence of allergic diseases in the region. Allergies affect about 50 million people in the Unites States every year. Asia Pacific is estimated to be the fastest growing region during the forecast period due to rising allergy patients and favorable government policies. Increasing pharmaceuticals market in Asia and increasing demand from developing countries such as India and China are driving the growth of the market.
Competitive insights
The global allergy diagnosis and therapeutics market revolves around the market of multinational players. However, some regional players also contributed significantly towards the growth of the market. Key players of the market are Biomérieux, Danaher Corporation, Hitachi Chemical Diagnostics, Inc., Siemens AG, Thermo Fisher Scientific, Inc, Hob Biotech Group, Hycor Biomedical, Lincoln Diagnostics, Inc, Omega Diagnostics Group PLC and so on. In order to sustain in the market, these players adopt different strategies such as merger acquisitions, product launch and so on. For example, In 2016, Thermofisher Scientific acquired Field Electrone & Ion(FEI)company in $4.2 billion deal.
Market segmentation
1. Allergy diagnostics and therapeutics market by allergens
2. Allergy diagnostics and therapeutics market by product
3. Allergy diagnostics and therapeutics market by test
4. Allergy diagnostics and therapeutics market by drug class
5. Allergy diagnostics and therapeutics market by end-user
OMR Report covers
• Comprehensive research methodology of global allergy diagnostics and therapeutics market
• This report also includes detailed and extensive market overview with Analyst insights & key market trends.
• Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies
impacting the global allergy diagnostics and therapeutics market.
• Insights about market determinants which are stimulating the global allergy diagnostics and therapeutics market
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.
1. REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. ANALYST INSIGHTS & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.2.2. RECOMMENDATION
2.2.3. CONCLUSION
2.3. REGULATIONS
2.3.1. UNITED STATES
2.3.2. EUROPEAN UNION
2.3.3. CHINA
2.3.4. INDIA
2.3.5. REST OF THE WORLD
3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. SURGING ENVIRONMENTAL POLLUTION
3.1.2. RISE IN GLOBAL HEALTHCARE EXPENDITURE
3.1.3. GROWING PREVALENCE OF ALLERGIC DISEASES
3.1.4. INCREASING DEMAND OF IVD TESTS FOR ALLERGY DIAGNOSIS
3.1.5. DEVELOPMENT OF TECHNOLOGICALLY ADVANCE DIAGNOSIS PRODUCT
3.2. RESTRAINTS
3.2.1. STRINGENT GOVERNMENT REGULATION
3.2.2. PRESENCE OF AMBIGUOUS REGULATORY FRAMEWORK
3.2.3. HIGH CAPITAL REQUIREMENTS
3.2.4. LACK OF AWARENESS
3.3. OPPORTUNITIES
3.3.1. INCREASING DEMAND FROM EMERGING MARKET
4. MARKET SEGMENTATION
4.1. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY ALLERGENS
4.1.1. DRUG ALLERGENS
4.1.2. INHALED ALLERGENS
4.1.3. FOOD ALLERGENS
4.1.4. OTHERS
4.2. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY PRODUCT
4.2.1. ASSAY KITS
4.2.2. INSTRUMENTS
4.2.3.1. LUMINOMETERS
4.2.3.2. IMMUNOASSAY ANALYZER
4.2.3.3. ELISA ANALYZER
4.2.3.4. OTHERS
4.2.3. SERVICES
4.3. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY TEST
4.3.1. IN-VIVO TEST
4.3.2. IN-VITRO TEST
4.4. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY DRUG CLASS
4.4.1. ANTIHISTAMINES
4.4.2. DECONGESTANTS
4.4.3. CORTICOSTEROIDS
4.4.4. MAST CELL STABILIZERS
4.4.5. LEUKOTRIENE INHIBITORS
4.4.6. NASAL ANTICHOLINERGIC
4.4.7. IMMUNOMODULATORS
4.4.8. AUTO INJECTABLE EPINEPHRINE
4.4.9. IMMUNOTHERAPY
4.5. GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET BY END-USER
4.5.1. HOSPITALS
4.5.2. DIAGNOSTIC LABORATORIES
4.5.3. ACADEMIC RESEARCH
4.5.4. OTHERS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES ANALYSIS
5.2. KEY COMPANY ANALYSIS
6. REGIONAL ANALYSIS
6.1. NORTH AMERICA
6.1.1. UNITED STATES
6.1.2. CANADA
6.1.3. REST OF NORTH AMERICA
6.2. EUROPE
6.2.1. UNITED KINGDOM
6.2.2. FRANCE
6.2.3. GERMANY
6.2.4. ITALY
6.2.5. SPAIN
6.2.6. REST OF EUROPE
6.3. ASIA PACIFIC
6.3.1. INDIA
6.3.2. CHINA
6.3.3. JAPAN
6.4. REST OF THE WORLD
7. COMPANY PROFILES
7.1. ALCON LABORETRIES, INC.
7.1.1. INTRODUCTION
7.1.2. ALCON PRODUCT PORTFOLIO
7.1.3. ALCON RECENT ACTIVITIES
7.2. ALLERCHECK, INC.
7.2.1. INTRODUCTION
7.2.2. ALLERCHECK, INC. PRODUCT PORTFOLIO
7.2.3. ALLERCHECK, INC. RECENT ACTIVITIES
7.3. ALLERGEN PLC
7.3.1. INTRODUCTION
7.3.2. ALLERGEN PLC PRODUCT PORTFOLIO
7.3.3. ALLERGEN PLC RECENT ACTIVITIES
7.4. ALLERGY THERAPEUTICS
7.4.1. INTRODUCTION
7.4.2. ALLERGY THERAPEUTICS RECENT ACTIVITIES
7.4.3. ALLERGYTHERAPEUTICS PRODUCT PORTFOLIO
7.5. BIOMÉRIEUX
7.5.1. INTRODUCTION
7.5.2. BIOMÉRIEUX RECENT ACTIVITIES
7.5.3. BIOMÉRIEUX PRODUCT PORTFOLIO
7.6. DANAHER CORPORATION
7.6.1. INTRODUCTION
7.6.2. DANAHER CORPORATION PRODUCT PORTFOLIO
7.6.3. DANAHER CORPORATION RECENT ACTIVITIES
7.7. HAL ALLERGY GROUP
7.7.1. INTRODUCTION
7.7.2. HAL ALLERGY RECENT ACTIVITIES
7.7.3. HAL ALLERGYPRODUCT PORTFOLIO
7.8. HITACHI CHEMICAL DIAGNOSTICS, INC.
7.8.1. INTRODUCTION
7.8.2. HITACHI CHEMICAL DIAGNOSTICS, INC. PRODUCT PORTFOLIO
7.8.3. HITACHI CHEMICAL DIAGNOSTICS, INC. RECENT ACTIVITIES
7.9. HOB BIOTECH GROUP
7.9.1. INTRODUCTION
7.9.2. HOB BIOTECH GROUP PRODUCT PORTFOLIO
7.9.3. HOB BIOTECH GROUP RECENT ACTIVITIES
7.10. HYCOR BIOMEDICAL
7.10.1. INTRODUCTION
7.10.2. HYCOR BIOMEDICAL PRODUCT PORTFOLIO
7.10.3. HYCOR BIOMEDICAL RECENT ACTIVITIES
7.11. LINCOLN DIAGNOSTICS, INC.
7.11.1. INTRODUCTION
7.11.2. LINCOLN DIAGNOSTICS, INC. PRODUCT PORTFOLIO
7.11.3. LINCOLN DIAGNOSTICS, INC. RECENT ACTIVITIES
7.12. MEDA PHARMACEUTICALS
7.12.1. INTRODUCTION
7.12.2. MEDA PHARMACEUTICALS PRODUCT PORTFOLIO
7.12.3. MEDA PHARMACEUTICALS RECENT ACTIVITIES
7.13. NIDEC CORPORATION
7.13.1. INTRODUCTION
7.13.2. NIDEC CORPORATION PRODUCT PORTFOLIO
7.13.3. NIDEC CORPORATION RECENT ACTIVITIES
7.14. OMEGA DIAGNOSTICS GROUP PLC
7.14.1. INTRODUCTION
7.14.2. OMEGA DIAGNOSTICS GROUP PLC PRODUCT PORTFOLIO
7.14.3. OMEGA DIAGNOSTICS GROUP PLC RECENT ACTIVITIES
7.15. QUEST DIAGNOSTICS, INC.
7.15.1. INTRODUCTION
7.15.2. QUEST DIAGNOSTICS, INC. PRODUCT PORTFOLIO
7.15.3. QUEST DIAGNOSTICS, INC. RECENT ACTIVITIES
7.16. SCHERING-PLOUGH CORPORATION
7.16.1. INTRODUCTION
7.16.2. SCHERING-PLOUGH CORPORATION PRODUCT PORTFOLIO
7.16.3. SCHERING-PLOUGH CORPORATION RECENT ACTIVITIES
7.17. SIEMENS AG
7.17.1. INTRODUCTION
7.17.2. SIEMENS AG RECENT ACTIVITIES
7.17.3. SIEMENS AG RODUCT PORTFOLIO
7.18. STALLERGENES GREER
7.18.1. INTRODUCTION
7.18.2. STALLERGENES GREER PRODUCT PORTFOLIO
7.18.3. STALLERGENES GREER RECENT ACTIVITIES
7.19. THERMOFISHER
7.19.1. INTRODUCTION
7.19.2. THERMOFISHER RECENT ACTIVITIES
7.19.3. THERMOFISHER PRODUCT PORTFOLIO
TABLE # 1GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, BY TYPE 2015-2022 ($ MILLION)
TABLE # 2GLOBAL ASSAY KITS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE # 3GLOBAL INSTRUMENTS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE # 4GLOBAL IMMUNOASSAY ANALYZERS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE # 5GLOBAL LUMINOMETERS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE # 6GLOBAL ELISA ANALYZER MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE # 7GLOBAL OTHER INSTRUMENTS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE # 8GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, BY ALLERGENS 2015-2022 ($ MILLION)
TABLE # 9GLOBAL DRUG ALLERGENS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE # 10GLOBAL FOOD ALLERGENS MARKET RESEARCH AND ANALYSIS, BY CONNECTOR, 2015-2022 ($ MILLION)
TABLE # 11GLOBAL INHALED ALLERGENS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE # 12GLOBAL OTHER ALLERGENS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE # 13GLOBAL INTERNAL HEXAGONAL CONNECTORS MARKET RESEARCH AND ANALYSIS, BY TEST, 2015-2022 ($ MILLION)
TABLE # 14GLOBAL IN-VITRO TEST MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE # 15GLOBAL IN-VIVO TEST MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE # 16GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, BY DRUG CLASS, 2015-2022 ($ MILLION)
TABLE # 17GLOBAL ANTIHISTAMINES MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE # 18GLOBAL DECONGESTANTS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE # 19GLOBAL CORTICOSTEROIDS MARKET RESEARCH AND ANALYSIS, BY PRODUCT, 2015-2022 ($ MILLION)
TABLE # 20GLOBAL MAST CELL STABILIZERS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE # 21GLOBAL LEUKOTRIENE INHIBITORS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE # 22GLOBAL NASAL ANTICHOLINERGIC MARKET RESEARCH AND ANALYSIS, BY TYPE 2015-2022 ($ MILLION)
TABLE # 23GLOBAL IMMUNOMODULATORS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE # 24GLOBAL AUTO INJECTABLE EPINEPHRINE MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE # 25GLOBAL IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE # 26GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS, BY END-USER 2015-2022 ($ MILLION)
TABLE # 27GLOBAL DIAGNOSTIC LABORATORIES MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
TABLE # 28GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE # 29GLOBAL ACADEMIC RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE # 30GLOBAL OTHER MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE # 31BIOMÉRIEUX PRODUCT PORTFOLIO
TABLE # 32BIOMÉRIEUX RECENT ACTIVITIES
TABLE # 33DANAHER CORPORATION PRODUCT PORTFOLIO
TABLE # 34DANAHER CORPORATION RECENT ACTIVITIES
TABLE # 35HITACHI CHEMICAL DIAGNOSTICS, INC PRODUCT PORTFOLIO
TABLE # 36HITACHI CHEMICAL DIAGNOSTICS, INC. RECENT ACTIVITIES
TABLE # 37SIEMENS AG PRODUCT PORTFOLIO
TABLE # 38SIEMENS AG RECENT ACTIVITIES
TABLE # 39THERMOFISHER PRODUCT PORTFOLIO
TABLE # 40THERMOFISHER RECENT ACTIVITIES
TABLE # 41HOB BIOTECH GROUP PRODUCT PORTFOLIO
TABLE # 42HOB BIOTECH GROUP RECENT ACTIVITIES
TABLE # 43HYCOR BIOMEDICAL PRODUCT PORTFOLIO
TABLE # 44HYCOR BIOMEDICAL RECENT ACTIVITIES
TABLE # 45LINCOLN DIAGNOSTICS, INC. PRODUCT PORTFOLIO
TABLE # 46LINCOLN DIAGNOSTICS, INC. RECENT ACTIVITIES
TABLE # 47OMEGA DIAGNOSTICS GROUP PLC PRODUCT PORTFOLIO
TABLE # 48OMEGA DIAGNOSTICS GROUP PLC RECENT ACTIVITIES
TABLE # 49STALLERGENES GREER PRODUCT PORTFOLIO
TABLE # 50STALLERGENES GREER RECENT ACTIVITIES
TABLE # 51QUEST DIAGNOSTICS, INC. PRODUCT PORTFOLIO
TABLE # 52QUEST DIAGNOSTICS, INC. RECENT ACTIVITIES
TABLE # 53HAL ALLERGY PRODUCT PORTFOLIO
TABLE # 54HAL ALLERGY RECENT ACTIVITIES
TABLE # 55ALCON PRODUCT PORTFOLIO
TABLE # 56ALCON RECENT ACTIVITIES
TABLE # 57ALLERCHECK, INC. PRODUCT PORTFOLIO
TABLE # 58ALLERCHECK, INC. RECENT ACTIVITIES
TABLE # 59NIDEC CORPORATION PRODUCT PORTFOLIO
TABLE # 60NIDEC CORPORATION RECENT ACTIVITIES
TABLE # 61ALLERGY THERAPEUTICS PRODUCT PORTFOLIO
TABLE # 62ALLERGY THERAPEUTICS RECENT ACTIVITIES
TABLE # 63MEDA PHARMACEUTICALS PRODUCT PORTFOLIO
TABLE # 64MEDA PHARMACEUTICALS RECENT ACTIVITIES
TABLE # 65ALLERGEN PLC PRODUCT PORTFOLIO
TABLE # 66ALLERGEN PLC RECENT ACTIVITIES
TABLE # 67ALLERGON AB PRODUCT PORTFOLIO
TABLE # 68ALLERGON AB RECENT ACTIVITIES
TABLE # 69SCHERING-PLOUGH CORPORATION PRODUCT PORTFOLIO
TABLE # 70SCHERING-PLOUGH CORPORATION RECENT ACTIVITIES
FIGURE # 1NORTH AMERICA MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE # 2US MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE # 3CANADA MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE # 4EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE # 5UK MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE # 6FRANCE MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE # 7GERMANY MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE # 8ITALY MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE # 9SPAIN MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE # 10ROE MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE # 11ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE # 12INDIA MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE # 13CHINA MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE # 14JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE # 15ROPAC MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE # 16REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2022
